MBMathieu Bergeron

Mathieu Bergeron

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mathieu Bergeron has a total of 57 co-authors. Here are the top co-authors by number of shared publications:

  • Alessandro de Alarcon

    Department of Otolaryngology‐Head and Neck Surgery University of Cincinnati Cincinnati Ohio USA

    3 shared publications
  • Camille Caron

    Department of Anesthesia Université de Montréal Montreal Quebec Canada

    3 shared publications
  • Erika Mercier

    Department of Otolaryngology–Head and Neck Surgery Harvard Medical School Boston USA

    3 shared publications
  • Alessandro de Alarcon

    Division of Pediatric Otolaryngology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA

    2 shared publications
  • Alix Pincivy

    Medical Library CHU Sainte Justine Montreal Quebec Canada

    2 shared publications
  • Annie Lapointe

    Division of Otolaryngology–Head and Neck Surgery, Department of Surgery Université de Montréal Montreal Quebec Canada

    2 shared publications

Latest Publications

  • Open Access

    Clinical Management and Outcomes of Neonatal Rhinitis Nasal Obstruction: A Scoping Review

    by Anthony Victor, Mathieu Bergeron

    Objective: Neonatal rhinitis represents an underdiagnosed yet potentially serious condition in newborns. Standardized diagnostic and treatment protocols remain lacking. The objective is to review the current literature on the etiology, diagnosis, and management of neonatal rhinitis in infants ≤8 months of age. Data Sources: PubMed, Medline, Embase, Google Scholar and Sofia (January 1980‐September 2025). Review Methods: A scoping review was conducted in accordance with PRISMA‐ScR guidelines. The inclusion criteria targeted studies involving neonates with nasal obstruction caused by mucosal edema or inflammatory conditions. Data were extracted regarding clinical presentation, diagnostic approaches, therapeutic strategies, and outcomes. Results: Five key studies were found, including retrospective chart reviews, case series, and narrative reports. Across the studies, neonatal rhinitis was consistently characterized by mucoid rhinorrhea, nasal congestion, stertor, poor feeding, and respiratory distress, often in afebrile newborns. Standard diagnostic tools included fibre‐optic endoscopy and CT imaging to exclude choanal atresia, pyriform aperture stenosis, and other etiologies. Conservative treatment approaches, such as saline irrigation, corticosteroid nasal drops (eg, dexamethasone), and nasopharyngeal airway placement, were favoured and proved efficient in most cases. Surgical intervention and more invasive interventions were reserved for severe or nonresponsive cases. Conclusion: Neonatal rhinitis is a clinically significant yet undercharacterized condition. Although the available evidence is limited, it suggests that conservative management, including topical corticosteroids and mechanical airway support, is commonly used and associated with favourable outcomes. This scoping review identifies gaps and underscores the need for research to better define and guide the management of this condition.

  • Open Access

    Pediatric Epiglottopexy: A Scoping Review of Indications, Techniques, Outcomes, and Complications

    by Karim Estephan, Mathieu Bergeron

    Objective: To map and synthesize the evidence on epiglottopexy in pediatric patients with laryngomalacia, epiglottic prolapse, and obstructive sleep apnea (OSA) with attention to indications, techniques, outcomes, complications, and evidence gaps. Data Sources: PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar were searched from January 1980 to May 2026 for English‐ and French‐language studies, supplemented by hand‐searching of reference lists. Review Methods: This scoping review followed PRISMA‐ScR guidelines. The review protocol was registered on OSF prior to data extraction. Eligible studies were original reports of pediatric patients (< 18 years) who underwent epiglottopexy for any indication. Two reviewers independently screened records and extracted data; findings were synthesized descriptively. Results: Twenty‐four studies (371 patients) published between 1987 and 2026 met inclusion criteria, comprising case reports, case series, and retrospective cohorts from 10 countries. Surgical approaches included endoscopic CO 2 laser or cautery‐assisted glossoepiglottopexy, transoral suture‐based epiglottopexy, transcervical external fixation, and robot‐assisted epiglottopexy. Indications spanned classic Type III laryngomalacia, epiglottic prolapse complicating tracheostomy‐dependent or syndromic airway disease, and increasingly, drug‐induced sleep endoscopy (DISE)‐confirmed epiglottic obstruction in children with refractory OSA. Respiratory improvement was consistently reported, swallowing function was largely preserved or improved, and complication and recurrence rates were low, with single‐procedure success in most cases. Conclusion: Epiglottopexy is reported to be safe and effective for pediatric epiglottic prolapse across diverse clinical contexts and techniques. DISE has expanded its indications to sleep‐state‐dependent epiglottic obstruction. Evidence remains limited by small, retrospective series; prospective studies with standardized DISE protocols, outcome measures, and longer follow‐up are needed. Level of Evidence: N/A.

  • Open Access

    The Burden of Airway Disease in Mucopolysaccharidoses: Evidence Across Subtypes

    by Julia Edward, Alix Pincivy, Mathieu Bergeron

    Objective: To synthesize the prevalence and subtype‐specific patterns of airway manifestations in mucopolysaccharidoses (MPS) and summarize related morbidity and mortality. Data Sources: PubMed, CINAHL, Ovid Embase, Ovid MEDLINE, and Ovid All EBM Reviews. Review Methods: PRISMA‐ScR guided scoping review of English and French‐language studies reporting airway manifestations in ≥ 5 patients up to June 2026. Pooled prevalences with 95% confidence intervals (CI) were estimated using proportional meta‐analysis. Results: Of 2359 records, 65 case series (3715 participants; Level 4 evidence) were included. Upper‐airway soft tissue hypertrophy was common: adenoid hypertrophy ranged from 52.5% (MPS IV; 95% CI, 21.0–82.1) to 78.5% (MPS I; 95% CI, 23.9–97.7); tonsillar hypertrophy ranged from 38.5% (MPS I; 95% CI, 17.5–64.9) to 59.5% (MPS II; 95% CI, 34.6–80.4). Macroglossia was frequent, with the highest prevalence in MPS II (79.7%; 95% CI, 16.5–98.7). Laryngotracheal involvement varied, with tracheal narrowing reaching 92.3% (95% CI, 7.0–99.9) in MPS II and 85.4% (95% CI, 38.3–98.2) in MPS IV. Obstructive sleep apnea was highly prevalent across subtypes (MPS I, 61.7%; 95% CI, 45.3–75.9; MPS II, 75.3%; 95% CI, 43.1–92.4; MPS VI, 83.7%; 95% CI, 48.0–96.6). Tracheotomy was required in 7.0% (95% CI, 4.9–9.9), and respiratory‐related deaths occurred in 10.4% (95% CI, 5.2–19.9) of patients with available data. Conclusion: Airway disease in MPS is common, multilevel, and clinically consequential, with substantial burdens of OSA and progressive laryngotracheal pathology. Early, systematic, longitudinal airway assessment is essential to guide counseling and management across MPS subtypes.

  • Open Access

    Drug‐Induced Sleep Endoscopy in Infants With Obstructive Sleep Apnea: Current Evidence and Knowledge Gaps

    by Melissa Bouhraoua, Christophe Salois, Mathieu Bergeron

    Objective: To map and synthesize the available evidence and evidence gaps on drug‐induced sleep endoscopy (DISE) in infants with obstructive sleep apnea (OSA), focusing on reported sites of obstruction, DISE‐associated management decisions, postoperative outcomes, safety, and limitations in current reporting. Data Sources: PubMed/MEDLINE/Embase/Google Scholar was searched for studies published in English and French from January 1980 to September 2025. Review Methods: This scoping review followed the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses extension for Scoping Reviews (PRISMA‐ScR) guidelines. Eligible studies included original reports describing infants under 12 months with OSA who underwent DISE. Two reviewers independently screened titles, abstracts, and full texts, extracted data with a standardized form, and synthesized results descriptively. Extracted variables included available polysomnography (PSG) parameters, DISE methodology, comparator airway evaluations when reported, DISE‐directed interventions, postoperative outcomes, and complications. Results: Eight observational studies published between 2013 and 2024 met inclusion criteria, involving 151 infants. DISE often revealed multilevel obstruction, most commonly involving the supraglottis (epiglottis, aryepiglottic folds, arytenoids; including sleep‐state laryngomalacia) and retrolingual airway. Contributors from the nasal and adenotonsillar regions were also reported. DISE findings were associated with variable interventions, most frequently supraglottoplasty and adenoidectomy/tonsillectomy, with selected cases requiring mandibular distraction, tongue‐lip adhesion, or tracheostomy. When postoperative PSG was available, indices generally improved (mean apnea‐hypopnea index [AHI] approximately 10.6 events/h preoperatively and 3 events/h postoperatively). No major DISE‐related complications were consistently described. Conclusion: In infants with OSA, DISE appears feasible and may identify dynamic, often multilevel obstruction, particularly supraglottic and retrolingual collapse. However, current evidence remains limited by small retrospective series, inconsistent PSG reporting, variable DISE protocols, and limited objective postoperative outcomes. Prospective studies with standardized DISE methods, uniform PSG reporting, defined outcome measures, and comparator airway evaluations are needed. Level of Evidence: 2.

  • Open Access

    CHARGE Syndrome: What an Otolaryngologist Should Know—A Systematic Review and Meta‐Analysis

    by Camille Caron, Massil Badji, Camille Prigent, Alix Pincivy, Erika Mercier, Mathieu Bergeron

    Objective: To synthesize the prevalence of otolaryngologic manifestations in CHARGE syndrome (CS) to support otolaryngologists in delivering comprehensive management. Data Sources: PubMed/MEDLINE, Embase, and Google Scholar were searched for English‐ and French‐language studies published from January 1980 through January 2025. Review Methods: This systematic review and proportional meta‐analysis adhered to PRISMA guidelines. Screening and extraction were performed (January‐May 2025) by 2 independent reviewers using a standardized template. Pooled prevalence estimates were generated using random‐effects models with 95% confidence intervals (CIs);heterogeneity was assessed with I 2 . Study quality was assessed with the Newcastle‐Ottawa Scale. Results: Seventy studies (1564 patients; predominantly case series) were included. Airway findings included choanal atresia (reported across 58 studies; unilateral 15.4%, 95% CI 11.6‐19.2; bilateral 31.5%, 95% CI 23.3‐39.7), laryngomalacia (8 studies; 27.7%, 95% CI 16.3‐28.1), and tracheostomy (13 studies; 23.6%, 95% CI 16.9‐27.5). Olfactory abnormalities were reported in 15 studies (28.8%, 95% CI 14.7‐42.9). Craniofacial findings included facial palsy (39 studies; 35.2%, 95% CI 29.8‐40.7) and cleft lip/palate (43 studies; 25.6%, 95% CI 23.1‐28.2). Otologic abnormalities were frequent, including chronic otitis media with effusion (11 studies; 54.5%, 95% CI 48.4‐60.7), semicircular canal hypoplasia/aplasia (29 studies; 73.6%, 95% CI 59.9‐85.2), cochlear hypoplasia (26 studies; 49.8%, 95% CI 37.4‐62.2), cochlear nerve hypoplasia (13 studies; 49.1%, 95% CI 34.4‐63.8), and sensorineural hearing loss (27 studies; 56.9%, 95% CI 52.7‐61.1). Conclusion: CS is associated with a substantial ENT disease burden extending beyond choanal atresia, including frequent airway compromise, olfactory dysfunction, craniofacial anomalies, and vestibulocochlear malformations. Early, comprehensive multidisciplinary assessment with otolaryngology involvement is warranted.

  • Open Access

    Congenital Intraoral Synechiae: A Scoping Review of Airway, Feeding, and Surgical Management.

    by Jason Bernier, Mathieu Bergeron

    To map the existing literature on congenital intraoral synechiae and summarize reported anatomic patterns, clinical presentation, associated anomalies/syndromes, and outcomes to inform standardized diagnostic and therapeutic approaches. PubMed, CINAHL, Embase, Web of Science, and Google Scholar were searched from January to April 2025, supplemented by reference list screening. This scoping review followed PRISMA-ScR recommendations. Eligible publications (1980-January 2025) were English or French reports with an abstract describing ≥1 patient with congenital intraoral soft-tissue synechiae. Two independent reviewers screened studies and extracted demographics, anatomy, symptoms, associated anomalies/syndromes, perioperative support, surgical/anesthetic techniques, and outcomes using a standardized Excel form. Data were summarized descriptively. 111 articles met the inclusion criteria, describing 134 patients. Alveolar synechiae were most common (70/134, 52.2%), followed by subglossopalatal (45/134, 33.6%) and glossopalatal (21/134, 15.7%); multiple synechiae types occurred in 10.4%. Restricted mouth opening was reported in 42.5%, feeding difficulties in 25.4%, and respiratory distress in 13.4%. Palatal clefts were present in 66.4%, and syndromic diagnoses included ankyloglossia superior syndrome and multiple pterygium syndromes (each 8.2%). Surgical excision was performed in 93.3%, most often within the first month of life. Among cases with reported outcomes, 80.6% recovered without complication; mortality was 6.7% overall, largely related to systemic disease. Congenital intraoral synechiae demonstrate marked phenotypic heterogeneity and frequent syndromic/multisystem associations. Early multidisciplinary evaluation, proactive airway/feeding planning, and timely surgical release are central to care. However, important gaps remain in the literature, notably the lack of standardized reporting and long-term outcome data.


  • Odynophagie (approche clinique)

    by Fany Mainville, Mathieu Bergeron

    Odynophagia denotes painful swallowing originating from lesions between the oropharynx and distal esophagus. Most primary-care presentations are viral; group A Streptococcus accounts for a subset of pharyngitis, whereas deep neck infections are uncommon yet carry substantial morbidity. Assessment focuses on risk factors (age, immunosuppression, tobacco/alcohol, exposures), symptom course (acute vs chronic), pain location, and airway “red flags” such as stridor, dyspnea, trismus, and muffled voice. Diagnostic tools include rapid antigen testing and culture for GAS, EBV/HIV assays, and pharyngeal NAAT for gonorrhea; flexible nasopharyngolaryngoscopy and contrast-enhanced cervical CT guide complicated cases. Management ranges from supportive care (analgesics, short steroid burst for severe pain) to targeted antibiotics for GAS and antifungals when indicated, up to IV broad-spectrum therapy and drainage for abscesses. Persistent symptoms warrant evaluation for head-and-neck or esophageal malignancy.

  • Open Access

    Intensive Care Unit Monitoring Post-Tonsillectomy in Children with Obstructive Sleep Apnea

    by Russell Schwartz, Carolanne Gagnon, Camille Caron, Michaël Sauthier, Mathieu Bergeron

    Objective: There is a lack of consensus regarding postoperative care for pediatric patients with obstructive sleep apnea (OSA) following adenotonsillectomy. At our institution, all patients with severe OSA are routinely admitted to the pediatric intensive care unit (PICU), raising concerns about the optimal use of health care resources. The objective of this study was to identify the risk factors necessitating PICU admission for pediatric patients who underwent adenotonsillectomy for OSA. Methods: An 8 year retrospective cohort study was conducted at a tertiary care pediatric hospital among consecutive patients with confirmed OSA undergoing adenotonsillectomy. All patients for whom a preoperative PICU request was made were included. A patient requiring PICU-level care was defined as needing respiratory support, such as intubation, positive pressure ventilation, or high-flow nasal cannula. Results: A total of 112 medical charts were included in the analysis. Only 13 patients (11.6%) had respiratory complications requiring PICU-level care. No preoperative or intraoperative variables were predictive of need for PICU. Early-postoperative need for supplemental oxygenation ( P = .002, OR = 6.7) and respiratory retraction ( P < .000, OR = 27.4) were significant predictors of PICU-level airway escalation. Nearly all patients (11/13) requiring escalated airway measures were identified in the first 4 hours postoperatively. Conclusion: A small subset of subjects with OSA required PICU-level care after adenotonsillectomy. Our data suggest that pediatric patients with OSA undergoing adenotonsillectomy may be safely monitored outside of an ICU setting for an extended period before determining eventual care setting.